Get access to our best features
Get access to our best features
Published 2 years ago

Psoriasis Patient’s Story Offers Hope for Those Struggling with Symptoms

Summary by Ground News
ILUMYA (tildrakizumab-asmn) is a prescription medicine used to treat adults with moderate-to-severe plaque psoriasis. Some patients might experience upper respiratory infections, injection site reactions and diarrhea. For patients who are 65 years or older and covered under Medicare Part B, there are treatment options for you.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics